Watch this interview and learn how advances in patient-centric drug delivery are transforming ten23 health's development strategies as a next-generation CDMO.
Prof. Dr. Hanns-Christian Mahler
Advertisement
Hanns-Christian Mahler is chief executive officer at ten23 health.
Articles by Prof. Dr. Hanns-Christian Mahler
Managing the intricacies of sterile product development is imperative for successful and compliant outcomes.
Advertisement
Latest Updated Articles
Managing the Complexity of Modern Sterile Product DevelopmentsPublished: February 16th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA, Duke University Planning Epinephrine Access Workshop for December
2
Industry Expert Panel Weighs CNPV Benefits, Risks, and Readiness: Part II
3
Industry Expert Panel Weighs CNPV Benefits, Risks, and Readiness: Part I
4
How ten23 health is Advancing Patient-Centric Drug Delivery
5
